31 unchanged sentences
We believe that Mr.
−Removed: qualified to serve on our board of directors because of his extensive experience at healthcare companies and in executive management.
+Added: Schlanger is qualified to serve on our board of directors because of his extensive experience at healthcare companies and in executive management.
Peter Anevski has served as our Chief Executive Officer and on our board of directors since January 2022.
13 unchanged sentences
from September 2019 to July 2020.
−Removed: Swartz holds a B.S.
+Added: Swartz holds a B.A.
in History from the University of Maryland and received her J.D.
27 unchanged sentences
Seidenberg has served on the board of directors of Atara Biotherapeutics since August 2012 and Vera Therapeutics, Inc.
−Removed: since June 2016.
+Added: since June 2016 and Acelyrin since 2020.
Seidenberg previously served on the boards of directors of Epizyme, Inc., from February 2008 to September 2019, Tesaro, Inc., from June 2011 to February 2019, and ARMO BioSciences, Inc.
8 unchanged sentences
Prior to that, Mr.
−Removed: Dean worked at Dignity Health (f/k/a Catholic
−Removed: Healthcare West) from 2000 to 2019, where he most recently served as Chief Executive Officer and President.
+Added: Dean worked at Dignity Health (f/k/a Catholic Healthcare West) from 2000 to 2019, where he most recently served as Chief Executive Officer and President.
Dean worked at Advocate Health Care as Chief Operating Officer from 1997 to 2000, and as Executive Vice President from 1995 to 1997.
39 unchanged sentences
Kevin Gordon has served as a member of our board of directors since October 2019.
−Removed: Gordon has also served as an advisor to 3i Group’s North American healthcare portfolio companies since January 2022, including currently as a director of privately held Q Holdco Limited, Sanisure, and Cirtec Medical Corp.
+Added: Gordon has also served on the board of directors of privately held Worldwide Clinical Trials, a global contract research organization, since December 2023 and as an advisor to 3i Group’s North American healthcare portfolio companies since January 2022, including currently as a director of privately held Q Holdco Limited, Sanisure, and Cirtec Medical Corp.
Gordon served on the board of directors of Veracyte, Inc., a genomic diagnostics company, from December 2016 until June 2022.
4 unchanged sentences
Gordon served as Executive Vice President and Chief Financial Officer of Teleflex Incorporated, a medical device company, from March 2007 until January 2010 and he held various senior corporate development positions there from 1997 to 2007.
−Removed: Prior thereto he held various senior positions, including Chief Financial Officer, at Package Machinery Company and senior manager and other positions at KPMG LLP.
+Added: Prior thereto he held various positions at Package Machinery Company and KPMG LLP.
Gordon holds a B.S.
4 unchanged sentences
He has been a Managing Director at Vestar Capital Partners, a private equity firm, since 2006.
−Removed: He currently serves on the boards of Quest Analytics, and Friday Health Plans.
+Added: He currently serves on the boards of Quest Analytics, and Nox Health.
From 1997 to 2005, Mr.
11 unchanged sentences
Jeff Park has served as a member of our board of directors since October 2019.
+Added: Since November 2023, Mr.
+Added: Park has served as the President of Waltz Health, a digital health business that helps patients and payers save costs on prescription drugs.
Park served from April 2019 until April 2022 as the Chairman and Chief Executive Officer of WellDyneRx, an independent pharmacy benefits manager.
−Removed: Park has served as a member of the board of directors for WellDyne Rx since April 2019.
He has served as a member of the board of directors for P3 Health Partners since December 2021.
6 unchanged sentences
Park holds a B.S.
−Removed: in Accounting from Brock University.
+Added: in Accounting from Brock
We believe that Mr.
9 unchanged sentences
Payson is currently serving on the board of directors of various private and not-for-profit companies including Access Clinical Partners, Smile Brands, HPM National Advisory Board at the Mailman School of Public Health at Columbia, USC Schaeffer Center Advisory Board and Executive Services Corporation of Southern California.
−Removed: Payson is also on the board of Kiva Foundation, a private charitable foundation organized by Dr.
+Added: Payson is also on the board of Elia Philanthropies (formerly Kiva Foundation), a private charitable foundation organized by Dr.
Payson and his wife in June 1998.
4 unchanged sentences
Payson served as a director at Geisel School of Medicine at Dartmouth, where he now serves as director emeritus.
+Added: From October 2016 to November 2023, Dr.
+Added: Payson was a board member of Smile Brands.
+Added: From June 2021 to July 2022 Dr.
+Added: Payson was Chairman of Implantable Provider Group.
From May 2017 to August 2019 Dr.
−Removed: Payson was a board member of The Center for Orthopaedic and Research Excellence, Inc.
+Added: Payson was a board member of Healthcare Outcomes Performance Company ("HOPCo") a subsidiary of The Center for Orthopaedic and Research Excellence, Inc.
Payson holds a B.S.
20 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.